Structural Aspects of Oligomerization in the Function of GPCRs

GPCR 功能中寡聚化的结构方面

基本信息

  • 批准号:
    8235922
  • 负责人:
  • 金额:
    $ 12.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-15 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

This KO2 application seeks support from NIDA for Dr. Marta Filizola's continued career development as an independent investigator. Her overall career goal is to contribute to the advancement in knowledge towards a better understanding of the molecular mechanisms underlying G-protein coupled receptor (GPCR)-mediated actions of drugs of abuse by means of computational methodologies that range from bioinformatics to modeling and simulation. In view of the recently established role and importance of GPCR oligomerization in receptor function, current research objectives of the Filizola laboratory are: a) To build refined three-dimensional (3D) models of GPCR oligomers; b) To build activated states of GPCR complexes in the interaction with their G-proteins; c) To study the dynamics of active and inactive GPCR complexes, so as to identify the molecular determinants responsible for allosteric modulation of GPCR function; d) To identify the molecular determinants responsible for the specificity of GPCR oligomerization and functional plasticity; and e) To develop, interpret and disseminate to the scientific community detailed information about the structural context of GPCR oligomerization and its experimentally determined implication for mechanisms of drug abuse. These research objectives are embodied in the proposed aims of the applicant's two currently funded NIDA projects, RO1 DA020032 and R21/R33 DA017976. In pursuit of these long-term research goals, the objectives of the current KO2 application include: 1) freeing the applicant from some teaching and administrative duties to devote nearly full time to develop further her research studies on GPCRs involved in mechanisms of drug abuse; 2) advancingthe applicant's progress in becoming a leader in computational studies of GPCR dimers/oligomers; and 3) intensifying the applicant's training in experimental techniques currently used to study structure, function, and dynamics of GPCR dimers/oligomers. Career development activities proposed in this application include interactions and collaborations designed to expose the applicant to novel computational methodologies as well as molecular and biophysical experimental techniques in vitro and in vivo.
本KO 2申请寻求NIDA对玛尔塔Filizola博士作为独立调查员的持续职业发展的支持。她的总体职业目标是通过从生物信息学到建模和模拟的计算方法,促进知识的进步,更好地理解G蛋白偶联受体(GPCR)介导的药物滥用行为的分子机制。鉴于最近确立的GPCR寡聚化在受体功能中的作用和重要性,Filizola实验室目前的研究目标是: GPCR寡聚体的精细三维(3D)模型; B)建立GPCR复合物与其G蛋白相互作用的活化状态; c)研究活性和非活性GPCR复合物的动力学,以便确定负责GPCR功能变构调节的分子决定因素; d)确定负责GPCR寡聚化特异性和功能可塑性的分子决定因素;和e)编写、解释并向科学界传播关于气相聚合酶链式反应寡聚化的结构背景及其通过实验确定的对药物滥用机制的影响的详细资料。这些研究目标体现在申请人的两个目前资助的NIDA项目,RO 1 DA 020032和R21/R33 DA 017976的拟议目标。为了实现这些长期的研究目标,目前的KO 2申请的目标包括:1)将申请人从一些教学和行政工作中解放出来,投入几乎全部的时间来进一步发展她对药物滥用机制中涉及的GPCR的研究; 2)促进申请人成为领导者的进展 在GPCR二聚体/寡聚体的计算研究中;以及3)加强申请人在目前用于研究GPCR二聚体/寡聚体的结构、功能和动力学的实验技术方面的培训。本申请中提出的职业发展活动包括旨在使申请人接触新型计算方法以及体外和体内分子和生物物理实验技术的互动和合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marta Filizola其他文献

Marta Filizola的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marta Filizola', 18)}}的其他基金

Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse
对涉及药物滥用的 GPCR 功能的分子和动态见解
  • 批准号:
    10163829
  • 财政年份:
    2018
  • 资助金额:
    $ 12.45万
  • 项目类别:
Molecular and Dynamic Insights into the Function of GPCRs Involved in Drug Abuse
对涉及药物滥用的 GPCR 功能的分子和动态见解
  • 批准号:
    10396651
  • 财政年份:
    2018
  • 资助金额:
    $ 12.45万
  • 项目类别:
Enhanced Molecular Dynamics Methods to Investigate GPCR Ligand Binding
研究 GPCR 配体结合的增强分子动力学方法
  • 批准号:
    9044052
  • 财政年份:
    2016
  • 资助金额:
    $ 12.45万
  • 项目类别:
Biophysical approaches to investigate the biological significance of GPCR dimers
研究 GPCR 二聚体生物学意义的生物物理方法
  • 批准号:
    9006811
  • 财政年份:
    2015
  • 资助金额:
    $ 12.45万
  • 项目类别:
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse
滥用药物靶向 GPCR 的动态机制
  • 批准号:
    8871703
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse
滥用药物靶向 GPCR 的动态机制
  • 批准号:
    8481527
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse
滥用药物靶向 GPCR 的动态机制
  • 批准号:
    8343893
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
Dynamic Mechanisms of GPCRs Targeted by Drugs of Abuse
滥用药物靶向 GPCR 的动态机制
  • 批准号:
    8661734
  • 财政年份:
    2012
  • 资助金额:
    $ 12.45万
  • 项目类别:
MECHANISTIC INSIGHTS INTO THE ?INSIDE-OUT? SIGNALING OF INTEGRINS
“由内而外”的机制洞察
  • 批准号:
    8364369
  • 财政年份:
    2011
  • 资助金额:
    $ 12.45万
  • 项目类别:
Efficiency of Enhanced Sampling Methods in GPCR Research
GPCR 研究中增强采样方法的效率
  • 批准号:
    8072081
  • 财政年份:
    2010
  • 资助金额:
    $ 12.45万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 12.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了